CLINICAL_TRIALS
ClinicalTrials.gov record update
DATO-BASE: A Phase 2 Trial of DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06176261
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:32.010548+00:00
- Published At
- 2025-07-30T00:00:00+00:00
- Record Updated At
- 2025-07-30
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Cancer", "Breast Cancer Female", "Metastatic Triple-Negative Breast Carcinoma", "ER Positive Breast Cancer", "HER2-negative Breast Cancer", "HER2 Negative Breast Carcinoma", "ER-negative Breast Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-07-30"- protocolSection.identificationModule.nctId
"NCT06176261"- protocolSection.identificationModule.officialTitle
"DATO-BASE: A Phase 2 Trial of DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.